DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells

被引:10
|
作者
Jablonska, Ewa [1 ]
Bialopiotrowicz, Emilia [1 ]
Szydlowski, Maciej [1 ]
Prochorec-Sobieszek, Monika [2 ]
Juszczynski, Przemyslaw [1 ]
Szumera-Cieckiewicz, Anna [2 ]
机构
[1] Inst Hematol & Transfus Med, Dept Expt Hematol, Indiry Gandhi 14, PL-02776 Warsaw, Poland
[2] Inst Hematol & Transfus Med, Dept Diagnost Hematol, Indiry Gandhi 14, PL-02776 Warsaw, Poland
关键词
NF-KAPPA-B; DEATH GENE BNIP3; C-CBL; UBIQUITIN LIGASES; MIR-155; EXPRESSION; ACTIVATION; SURVIVAL; SYK; INHIBITION;
D O I
10.1016/j.exphem.2020.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MicroRNA-155 (MiR-155) is involved in normal B-cell development and lymphomagen-esis, affecting cell differentiation, motility, and intracellular signaling. In this study, we searched for new targets of MiR-155 potentially involved in deregulation of the B-cell receptor pathway (BCR) in diffuse large B-c ell lymphoma (DLBCL). We report that MiR-155 represses DEPTOR (an mTOR phosphatase) and c-CBL (SYK ubiquitin E3 ligase) through direct 30-untranslated region interactions. In primary DLBCLs, MiR-155 exhibits a reciprocal expression pattern with DEPTOR and c-CBL. Inhibition of MiR-155 decreased expression of NFKB target genes and sensitized DLBCL cells to ibrutinib, confirming the role of MiR-155 in the modulation of BCR signaling. As the function of DEPTOR in DLBCLs has never been addressed, we first evaluated its expression in a series of 76 newly diagnosed DLBCL patients. DEPTOR protein expres-sion was markedly lower in more aggressive nongerminal center-like (non-GCB) DLBCLs than in GCB tumors. In cell line models, inhibition of DEPTOR expression favored the migration of DLBCL cells toward the CXCL12 gradient. Finally, loss or gain of DEPTOR modulated the expression of specific pro-inflammatory cytokines and chemokines. We thus identified DEPTOR as a new MiR-155 target that is differentially expressed between GCB-and non-GCB-type DLBCLs and modulates cell migration and cytokine expression in DLBCL cells. (C) 2020 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:56 / +
页数:14
相关论文
共 50 条
  • [1] MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma
    Jung, Inkyung
    Aguiar, Ricardo C. T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (01) : 138 - 140
  • [2] The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma
    Koumpis, Epameinondas
    Georgoulis, Vasileios
    Papathanasiou, Konstantina
    Papoudou-Bai, Alexandra
    Kanavaros, Panagiotis
    Kolettas, Evangelos
    Hatzimichael, Eleftheria
    BIOMEDICINES, 2024, 12 (12)
  • [3] Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma
    Rai, Deepak
    Karanti, Shailaja
    Jung, Inkyung
    Dahia, Patricia L. M.
    Aguiar, Ricardo C. T.
    CANCER GENETICS AND CYTOGENETICS, 2008, 181 (01) : 8 - 15
  • [4] MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma
    Zhu, Fu-qiang
    Zeng, Li
    Tang, Na
    Tang, Ya-ping
    Zhou, Bo-ping
    Li, Fang-fang
    Wu, Wei-gang
    Zeng, Xiao-bing
    Peng, Shu-song
    ONCOLOGY RESEARCH, 2016, 24 (06) : 415 - 427
  • [5] MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma
    Due, Hanne
    Schonherz, Anna Amanda
    Ryo, Laura
    Primo, Maria Nascimento
    Jespersen, Ditte Starberg
    Thomsen, Emil Aagaard
    Roug, Anne Stidholt
    Xiao, Min
    Tan, Xiaohong
    Pang, Yuyang
    Young, Ken H.
    Bogsted, Martin
    Mikkelsen, Jacob Giehm
    Dybkaer, Karen
    BLOOD ADVANCES, 2019, 3 (07) : 1185 - 1196
  • [6] MICRORNA-155 CONTROLS VINCRISTINE SENSITIVITY AND PREDICTS SUPERIOR CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA
    Due, H.
    Schonherz, A. A.
    Ryo, L. B.
    Roug, A. S.
    Johnsen, H. E.
    Bogsted, M.
    Mikkelsen, J. G.
    Dybkaer, K.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 12 - 12
  • [7] Beneficial Effect of Microrna-155 in Vincristine Response and Clinical Outcome in Especially GCB Diffuse Large B-Cell Lymphoma
    Due, Hanne
    Schonherz, Anna Amanda
    Ryo, Laura Barett
    Roug, Anne Stidsholt
    Johnsen, Hans Erik
    Bogsted, Martin
    Mikkelsen, Jacob Giehm
    Dybkaer, Karen
    BLOOD, 2017, 130
  • [8] Evaluation of latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma
    Wu, Xue
    Wang, Fei
    Li, Yuan
    Wang, Xiyong
    Liu, Ping
    Zhang, Haijun
    Ge, Zheng
    Zhang, Xiaoping
    Gao, Chong
    Chen, Baoan
    ONCOLOGY LETTERS, 2018, 15 (06) : 9725 - 9734
  • [9] MicroRNA Expression Profiling of Diffuse Large B-Cell Lymphoma
    Veryaskina, Yu. A.
    Titov, S. E.
    Kovynev, I. B.
    Fyodorova, S. S.
    Shebunyaeva, Ya. Yu.
    Antonenko, O. V.
    Pospelova, T. I.
    Zhimulev, I. F.
    MOLECULAR BIOLOGY, 2023, 57 (03) : 475 - 481
  • [10] MicroRNA Expression Profiling of Diffuse Large B-Cell Lymphoma
    Yu. A. Veryaskina
    S. E. Titov
    I. B. Kovynev
    S. S. Fyodorova
    Ya. Yu. Shebunyaeva
    O. V. Antonenko
    T. I. Pospelova
    I. F. Zhimulev
    Molecular Biology, 2023, 57 : 475 - 481